Skip to content
Optionomics Free · No account needed

Earnings analysis · 10-Q

CRDO earnings analysis

Filed September 2, 2026 · Our reading of the company's report

The latest report

Credo delivered Q1 FY2027 revenue of $479.003 million and non-GAAP diluted EPS of $1.20, beating consensus revenue of $471.515 million and EPS of $1.12. The associated Q2 revenue outlook was raised to $525 million-$535…

Read full summary

Credo delivered Q1 FY2027 revenue of $479.003 million and non-GAAP diluted EPS of $1.20, beating consensus revenue of $471.515 million and EPS of $1.12. The associated Q2 revenue outlook was raised to $525 million-$535 million from $465 million-$475 million, supporting a bullish earnings trajectory. However, the expected Q2 GAAP gross-margin range of 62.9%-64.9% signals potential margin compression, and the 440,000-share CEO trading plan creates a modest supply overhang.

Read the original on SEC.gov

Reported figures

Earnings per share
$1.2

What stood out

  • Revenue beat and strong year-over-year growth

    Q1 FY2027 revenue was $479.003 million, exceeding the $471.515 million consensus estimate by $7.488 million, or 1.6%. Revenue also increased 114.7% year over year.

  • EPS exceeded consensus by $0.08

    Non-GAAP diluted EPS was $1.20 versus the $1.12 consensus estimate, a $0.08 beat or 7.1%.

  • Revenue outlook raised materially

    Q2 FY2027 revenue outlook of $525 million-$535 million was raised from the prior $465 million-$475 million outlook, representing a $60 million-$70 million increase at the respective endpoints.

  • Market-risk profile unchanged

    Management reported no material changes to the company’s market-risk assessment during the three months ended August 1, 2026.

  • Internal controls remained effective

    Disclosure controls and procedures were concluded effective at the reasonable-assurance level as of August 1, 2026, with no change in internal control over financial reporting during the quarter.

What to watch

  • Forward gross-margin compression

    Expected Q2 GAAP gross margin of 62.9%-64.9% is below the reported Q1 non-GAAP gross margin of 67.0%-69.0% cited in the associated outlook, indicating potential margin pressure despite higher revenue expectations.

  • Potential insider share-sale overhang

    The CEO’s Rule 10b5-1 plan permits the sale of a maximum of 440,000 ordinary shares between September 14, 2026 and September 14, 2027, creating a potential source of insider selling pressure.

  • Uncertain litigation exposure

    The company states that litigation outcomes cannot be predicted with certainty and that litigation may impose defense and settlement costs, although it was not presently party to litigation expected to have a material adverse effect as of September 2, 2026.

  • Controls do not eliminate all error risk

    The company disclosed that its controls provide reasonable, not absolute, assurance and cannot prevent all error or fraud, reflecting residual financial-reporting control risk.

  • No new formal risk-factor changes

    The filing states that there were no material changes to previously disclosed risk factors from the May 2, 2026 Form 10-K, so no new filing-specific risk-factor developments were identified.

Management's outlook

The filing text provided does not include numeric guidance, but the associated Q2 FY2027 outlook was revenue of $525 million-$535 million, raised from the prior $465 million-$475 million outlook. Expected Q2 GAAP gross margin was 62.9%-64.9% and non-GAAP gross margin was 67.0%-69.0%.

Earlier filings 1

10-K · June 15, 2026

Credo Technology Group reported remarkable growth in fiscal 2026, with revenue up 205.7% year-over-year to $1.34 billion, driven by increased demand for its Active Electrical Cables (AECs). The company achieved…

This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.